Veterans’ RightsAn independent resource for veterans
← All decisions
Denied

The Board denied the veteran's claims for increased ratings for recurrent bilateral conjunctivitis and pterygium, finding that the evidence did not support a higher rating under the applicable VA rating criteria.

The deciding factor: The Board determined that there was no medical evidence to support an increase in disability ratings beyond 10 percent for conjunctivitis or any compensable rating for pterygium based on current visual acuity and lack of active pathology.

Claimed conditions
recurrent bilateral conjunctivitis, recurrent bilateral pterygium
How they argued it
Direct service connection
Exposure basis
None
Rating assigned
None in this decision
Decision date
May 31, 2000
Citation
0014171

This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Look up the original decision on VA.gov (opens in a new tab) using citation 0014171.

What this means for you

A denial is a starting point, not the end of the road. You can see why this claim fell short — and, if you are still inside the one-year window, the appeal lanes that may remain open to you.

What you can do next

Related decisions

Other Board decisions on a similar condition or argued the same way.

Free starter guide for your own claim

Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.

We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.

We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.

This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.